StockNews.AI
SBRA
StockNews.AI
197 days

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call; Declares Common Dividend

1. Sabra will release Q4 2024 earnings on February 19, 2025. 2. A conference call is scheduled for February 20, 2025, at 10 AM PT. 3. A quarterly cash dividend of $0.30 per share declared, payable on February 28, 2025.

5m saved
Insight
Article

FAQ

Why Bullish?

The declared dividend signals financial strength, potentially boosting investor confidence.

How important is it?

Earnings release and dividend can materially affect SBRA's stock performance.

Why Short Term?

The upcoming earnings report and dividend will have immediate market effects.

Related Companies

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call; Declares Common Dividend

TUSTIN, Calif.--()--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 fourth quarter earnings release on February 19, 2025, after the close of trading.

A conference call with a simultaneous webcast to discuss the 2024 fourth quarter results will be held on Thursday, February 20 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596.

The webcast URL is https://events.q4inc.com/attendee/595686468. A digital replay of the call will be available on our website at www.sabrahealth.com.

Also, on February 3, 2025, Sabra’s board of directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on February 28, 2025, to common stockholders of record as of the close of business on February 14, 2025.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com

Related News